Introduction
============

Schistosomiasis is a major neglected helminthic disease which remains a serious public health problem in many developing countries in tropical and subtropical regions. There are approximately 200 million people infected and more than 700 million people at risk of becoming infected [@B1],[@B2]. Schistosomiasis japonica, caused by infection with *Schistosoma japonicum*, leads to severe pathology such as granuloma formation in the liver, periportal fibrosis and portal hypertension in chronic infections [@B3], but there is no definitive host vaccine for *S. japonica.*Since the mechanisms underlying the immunologic response to schistosomiasis are not well described, better understanding would be helpful in vaccine development and therapies.

CD4^+^ T cells play an important role in both host immune responses against *Schistosoma* and immunopathology in schistosomiasis [@B4]. Naive CD4^+^T helper (Th) cells recognize diverse antigens of *Schistosoma* to differentiate into distinct effector subsets, including Th1, Th2, Th17, T regulatory (Treg) and Tfh cells. Hepatic granuloma formation was upregulated by Th2 and Th17 cells secreting IL-4 and IL-17 respectively [@B5],[@B6], and downregulated by Th1 and Treg cells[@B7],[@B8]. Tfh has recently been recognized as a separate subset of CD4^+^ T cells that is mainly responsible for assisting B cells to induce antibody response[@B9]. Tfh cells are characterized by high expression levels of the CD28 family members, PD1 and ICOS, as well as the chemokine receptor CXCR5. B-cell lymphoma 6 (BCl-6) and c-Maf are two important transcriptional factors that control the transcriptional signature of Tfh cells[@B10]-[@B12]. In addition, cytokine interleukin 21 (IL-21) from Tfh cells enhance humoral immune responses[@B13],[@B14]. Recently, a study regarding Tfh cells has been reported that showed Tfh cells can promote liver pathology in mice during *S. japonicum*infection[@B15], but little is known about the role of circulating Tfh cells in human schistosomiasis infection.

Most Tfh cells are located in the GC zone of secondary lymph nodules and therefore hard to access[@B16]. However, several studies have also detected Tfh cells in peripheral blood[@B17] and circulating Tfh cells have some features of GC Tfh cells[@B18]. Circulating Tfh cells may act as a counterpart, enabling measurement of GC Tfh cells and could be used to study Tfh cells. The role of circulating Tfh cells has been explored in patients with autoimmune diseases such as primary Sjogren\'s syndrome (pSS) and autoimmune thyroid disease (AITD), and some infectious diseases such as HIV and chronic hepatitis B (CHB)[@B19]-[@B21]. In this study, we examined the frequencies of Tfh cells and associated molecules in chronic schistosomiasis patients and healthy controls (HC) to investigate the potential roles of circulating Tfh cells. This study may provide novel insights regarding the role of circulating Tfh cells in patients with chronic schistosomiasis.

Materials and Methods
=====================

Ethics statement
----------------

Ethical approval for the collection and examination of human feces and blood samples was obtained from the Ethics Committee of the National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, China (reference no. 2012-12). The objectives, procedures and potential risks were verbally explained to all participants. Written informed consent was obtained from all the study participants.

Collection of study subjects
----------------------------

Our study was carried out in Dongting Lake Basin, Hunan Province, China, where schistosomiasis is endemic. We detected *Schistosoma*eggs in feces, and soluble egg antigen (SEA) IgG and indirect hemagglutination antibody (IHA) in sera, in study subjects. Patients with chronic schistosomiasis are asymptomatic carriers with no fever or fatigue, but were designated as suffering chronic schistosomiasis based on positive results from fecal egg, SEA IgG and IHA analyses, past medical history of infection, and frequent contact with cercariae in water. Healthy controls were selected by negative results from fecal egg, SEA IgG and IHA analyses and had no history of schistosomiasis.

Cell isolation
--------------

Sera were collected and stored at -80°C for detecting cytokine levels and specific antibodies against *S. japonicum*. Peripheral blood mononuclear cells (PBMCs) were isolated by standard Ficoll-density gradient centrifugation and washed in FACS buffer (5% FBS, 0.1% NaN~3~ in PBS) before surface staining. CD4^+^T cells were purified from PBMCs using human CD4 MicroBeads (Miltenyi Biotec, USA) according to the manufacturer\'s instructions.

Flow cytometric analysis
------------------------

PBMCs were immunostained with fluorescein isothiocyanate (FITC)-ICOS, phycoerythrin (PE)-CD4 (eBioscience, USA), and APC-CXCR5, PE-Cy7-PD-1 (BioLegend, USA) monoclonal antibodies according to the manufacturers\' protocols. The stained cells were then analyzed using a CyAn ADP analyzer (Beckman Coulter) and data were analyzed with FlowJo software.

Enzyme-linked immunosorbent assay (ELISA) analysis of cytokine and *S. Japonicum*-specific antibodies
-----------------------------------------------------------------------------------------------------

The concentration of serum IL-21 was determined using a human IL-21 ELISA Ready-SET-Go kit (eBioscience, USA) according to the manufacturer\'s protocol. All determinations were performed in triplicate. SEA were coated on plates, then the sera from schistosomiasis patients and healthy controls were tested for the presence of anti-SEA IgG, IgG1 and IgG4 antibodies by ELISA. All samples were analyzed in triplicate using the average of the optical density (OD) 450 nm values to calculate concentrations.

Real-time polymerase chain reaction
-----------------------------------

To detect the mRNA expression of Bcl6, c-Maf and IL-21, total RNA was extracted from CD4^+^ T cells using TRIzol reagent and cDNA was synthesized according to the manufacturer\'s instructions (TaKaRa, Japan). Each gene was amplified in triplicate using SYBR Supermix (TaKaRa) and a CFX960 analysis system (Applied Biosystems, USA). The PCR amplification program was as follows: an initial denaturation at 95°C for 5 min, followed by 40 amplification cycles at 95°C for 10 s, 60°C for 30 s. The fluorescence values were collected at 60°C. Concentration differences of cDNA were normalized to β-actin. Primer sequences were: IL-21 sense, 5\'-CACAGACTAACATGCCCTTCAT-3\' and antisense, 5\'-GAATCTTCACTTC CGTGTGTTCT-3\'; Bcl-6 sense, 5\'-AAGGCCAGTGAAGCAGAGA-3\', and antisense, 5\'-CCGATAGGCCATGATGTCT-3\'; c-Maf sense, 5\'- CAAGCTAGAAGCGCCCC-3\', and antisense, 5\'- AGTTCTGATGCCATTCTCCTG-3\'; β-actin sense 5\'-AGCGAGCATCCCCCAAAGTT-3\' , and antisense 5\'-GGGCACGAAGGCTCATCATT -3\'.

Statistical analysis
--------------------

All data are presented as mean ± standard deviation. The differences between two groups were analyzed by independent t-test or Mann-Whitney U-test using SPSS19.0. The correlation between groups was tested using Spearman\'s rank correlation. A two-sided *p* value of \< 0.05 was considered statistically significant.

Results
=======

Characteristics of study subjects
---------------------------------

Eleven chronic schistosomiasis patients (aged 47 ± 5.22) and 10 healthy controls (aged 42 ± 10.05) were enrolled in the study. They were all male and had no significant difference in age (*p*= 0.302). Peripheral blood samples were obtained from all patients and healthy controls.

Higher frequency of CXCR5^+^ CD4^+^ Tfh cells in the peripheral blood of chronic schistosomiasis patients
---------------------------------------------------------------------------------------------------------

To determine circulating Tfh cell immune function, 11 schistosomiasis patients and 10 healthy controls were recruited. The frequency of circulating CXCR5^+^CD4^+^Tfh cells within the CD4^+^T cell population was monitored by flow cytometry (Fig. [1](#F1){ref-type="fig"}A). As shown in Fig. [1](#F1){ref-type="fig"}B, the frequency of CXCR5^+^CD4^+^Tfh cells was significantly higher in chronic schistosomiasis patients than in the HC group (*p* \< 0.05).

Increased expression of ICOS and PD-1 in chronic schistosomiasis patients
-------------------------------------------------------------------------

A significantly higher frequency of CXCR5^+^CD4^+^ Tfh cells was observed in the chronic schistosomiasis patients than in the HC group. Thus, it was important to determine whether the expression of markers typically associated with Tfh cells was altered. The function of Tfh cells is closely related to the expression of ICOS and PD-1. The phenotype of Tfh cells was assessed in this study by flow cytometry (Fig. [2](#F2){ref-type="fig"}A, 2D). Notably, the expression of ICOS was increased in CXCR5^+^CD4^+^ Tfh cells in chronic schistosomiasis patients compared to healthy controls (*p* \< 0.05) (Fig. [2](#F2){ref-type="fig"}B-C). Likewise, high expression of PD-1 was observed in chronic schistosomiasis patients compared to healthy subjects (*p* \< 0.05) (Fig. [2](#F2){ref-type="fig"}E-F).

Levels of IL-21 in sera correlated with PD-1^high^ CXCR5^+^CD4^+^ Tfh cells
---------------------------------------------------------------------------

IL-21 is a typical cytokine produced by Tfh cells and can enhance B cells to produce antibodies. As expected, the expression of IL-21 mRNA in CD4^+^ T cells of patients was increased compared with healthy controls (Fig. [3](#F3){ref-type="fig"}A). Moreover, the levels of IL-21 in sera were significantly higher in patients than in HC (Fig. [3](#F3){ref-type="fig"}D). The levels of serum IL-21 positively correlated with PD-1^high^ CXCR5^+^CD4^+^ Tfh cells in schistosomiasis patients (Fig. [3](#F3){ref-type="fig"}J). However, there was no significant correlation between IL-21 levels and CXCR5^+^CD4^+^ Tfh cells or ICOS^high^ CXCR5^+^CD4^+^ Tfh cells in patients with schistosomiasis (Fig.[3](#F3){ref-type="fig"}H-I). Moreover, there were no relationships between IL-21 levels and CXCR5^+^CD4^+^ Tfh cells, ICOS^high^ CXCR5^+^CD4^+^ Tfh cells, or PD-1^high^ CXCR5^+^CD4^+^ Tfh cells in HC (Fig. [3](#F3){ref-type="fig"}E-G). A previous study showed that Bcl6 and c-Maf cooperate to ensure the differentiation of human Tfh [@B12] . We therefore also assessed the expression of transcription factor Bcl-6 and c-Maf in schistosomiasis patients and healthy controls. However, the results of the qPCR assays showed that Bcl-6 and c-Maf mRNA expression levles in CD4 ^+^T cells of patients were similar to those in controls (Fig. [3](#F3){ref-type="fig"}B-C).

Levels of serum SEA specific antibodies
---------------------------------------

Because of the high frequency of Tfh cells and the upregulation of ICOS and PD1 in patients with chronic schistosomiasis, we evaluated whether the function of Tfh cells was changed in the patients. Tfh cells are mainly responsible for assisting B cells to induce antibodies. In chronic schistosomiasis, SEA-specific antibodies may be beneficial for the hosts and also have high value for the detection of schistosomiasis. We determined the SEA-specific IgG, IgG1, and IgG4 levels in sera of study subjects by ELISA. SEA specific IgG, IgG1 and IgG4 levels were high in chronic schistosomiasis patients but negative or low in healthy controls (Fig. [4](#F4){ref-type="fig"}).

The levels of serum SEA specific antibodies correlated with the frequency of circulating PD1^+^ CXCR5^+^ CD4^+^ Tfh cells in schistosomiasis patients
-----------------------------------------------------------------------------------------------------------------------------------------------------

SEA specific antibody levels were significantly higher in chronic schistosomiasis patients than in healthy controls. We also analyzed whether SEA specific antibodies correlated with Tfh cells in chronic schistosomiasis patients. Positive correlation was found between the levels of SEA specific IgG, IgG1, IgG4 and the frequency of PD1^+^CXCR5^+^CD4^+^ Tfh cells (Fig.[5](#F5){ref-type="fig"}G-I). However, no significant correlation was observed between the percentages of other circulating Tfh cells and SEA specific antibodies in sera (Fig. [5](#F5){ref-type="fig"}A-F).

Discussion
==========

More and more studies have focused on the role of Tfh cells in infectious and autoimmune diseases. Recent work indicated that Tfh cells can control antigen specific B cell immunity [@B22] and help the production of antibodies in response to foreign antigens [@B23]. However, the mechanisms by which Tfh cells and associated molecules regulate B cell production of antibodies in humans remain largely unknown. Several studies indicated that the frequency of Tfh cells in patients with autoimmune diseases such as systemic lupus erythematosus and autoimmune thyroid disease was not significantly higher than in healthy controls [@B24]. In contrast, paradoxical results have been obtained in that a higher frequency of Tfh cells was observed in patients with chronic HIV infection [@B14] and chronic HBV infection [@B25] than in HC groups. Our findings showed that the frequencies of CXCR5^+^CD4^+^ Tfh cells were increased in chronic schistosomiasis patients compared to healthy controls. In addition to the increased frequency of these cells, the phenotype of CXCR5^+^CD4^+^ Tfh cells was altered. The expression of ICOS and PD-1 in chronic schistosomiasis patients was significantly increased compared to healthy controls. This indicated that chronic schistosomiasis infection induces CXCR5^+^CD4^+^Tfh cell differentiation.

The function of Tfh cells is closely related to the expression of markers such as CXCR5, PD-1, IL-21, ICOS and Bcl6. PD-1 plays a major role in inhibiting T cell responses. One study indicated that PD-1 was increased during a viral infection to inhibit chronically activated T cells from causing immunopathology or becoming autoreactive [@B26]. However, another recent study indicated that the expression of PD-1 in Tfh cells regulates the formation of GC, the survival of plasma cells, and IL-21 production [@B27]. In the present study, the expression of PD-1 was increased in CXCR5^+^CD4^+^Tfh cells in patients with chronic schistosomiasis infection compared to healthy controls. IL-21 is a known critical cytokine for the formation of GC, the development of Tfh cells with ICOS or PD-1 expression, and the production of antibodies [@B28],[@B29]. In some autoimmune diseases, the levels of IL-21 were significantly associated with the frequency of circulating Tfh cells with ICOS or PD-1 expression [@B30]. Higher expression of IL-21 mRNA and higher levels of IL-21 in serum were observed in chronic schistosomiasis patients. Moreover, the levels of IL-21 in serum positively correlated with the frequency of PD-1^high^ CXCR5^+^CD4^+^ Tfh cells in chronic schistosomiasis patients. Tfh cells are mainly responsible for assisting B cells to induce antibody response. SEA specific antibodies are usually how schistosomiasis is diagnosed, in addition to providing protection for the host. Therefore, we further investigated the relationship between circulating Tfh cells and SEA antibodies (SEA IgG, IgG1, and IgG4) in sera from chronic schistosomiasis patients. We found that the frequencies of circulating PD-1^high^ CXCR5^+^CD4^+^ Tfh cells positively correlated with the concentration of the SEA antibodies. However, no significant correlation was observed between the percentages of CXCR5^+^CD4^+^ Tfh cells or ICOS^high^ CXCR5^+^CD4^+^ Tfh cells and SEA-specific antibodies in sera. Thus, our data suggest that PD-1^high^ CXCR5^+^CD4^+^ Tfh cells may be involved in the production of SEA antibodies by the secretion of IL-21 in chronic schistosomiasis patients. The mechanism of PD-1^high^ CXCR5^+^CD4^+^ Tfh in regulating antibody production in the schistosomiasis will be investigated in future studies.

High expression of ICOS was also observed in chronic schistosomiasis patients compared to healthy controls. ICOS belongs to the CD28 family and plays an important role in Tfh cell recruitment to the follicle and maintenance of Tfh cells. It has been shown that ICOS deficiency in humans and mice causes a reduction in the number of Tfh cells and B cell maturation defects [@B31],[@B32]. Recent study identified that ICOS expression in Tfh cells participated in the formation of hepatic granuloma in mice infected with *S. japonicum* [@B13]. These chronic patients are asymptomatic carriers; therefore, we inferred that only PD-1^high^ CXCR5^+^CD4^+^ Tfh cells correlate with Abs. Further studies are needed to determine whether the expression of ICOS in CXCR5^+^CD4^+^ Tfh cells was associated with liver damage in different stages of schistosomiasis.

The transcription factors, Bcl-6 and c-Maf, were selectively expressed in Tfh cells. They are essential for the differentiation of Tfh cells, but we did not observe increased mRNA levels of Bcl-6 and c-Maf in serum samples from patients with chronic schistosomiasis compared to healthy controls. A previous study demonstrated that GC Tfh cells expressed high levels of Bcl-6, while circulating CXCR5^+^CD4^+^Tfh cells failed to express increased levels of Bcl-6 [@B33]. Our data consistently indicated that the expression levels of Bcl-6 and c-Maf mRNA were not raised in chronic schistosomiasis in circulating Tfh cells.

Conclusions
===========

Our study reveals that circulating Tfh cells may be involved in immune responses in chronic schistosomiasis infection via markers and secreted cytokines. Our data indicated that frequencies of CXCR5^+^CD4^+^ Tfh cells and the expression of ICOS and PD-1 were significantly higher in chronic schistosomiasis patients than in HC. Moreover, PD-1^high^ CXCR5^+^CD4^+^ Tfh cell levels positively correlated with IL-21 cytokine levels and the concentration of SEA-specific antibodies in sera from patients with chronic schistosomiasis, indicating that PD-1^high^ CXCR5^+^CD4^+^ Tfh cells might promote production of SEA specific antibodies by secretion of IL-21 in chronic schistosomiasis patients. The mechanism of PD-1^high^ CXCR5^+^CD4^+^ Tfh in regulating B-cell responses and antibody production will be investigated in future studies.
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![**Flow cytometry analysis of CXCR5^+^ CD4^+^ Tfh cells in schistosomiasis patients and healthy controls.**Isotype controls were used to determine the positive cells. All of the values were gated on CD4^+^ cells. (A) Values in the upper right quadrant correspond to the percentage of CXCR5^+^ CD4^+^ Tfh cells in the total CD4^+^ T cells. (B) The correlation between the percentages of CXCR5^+^ CD4^+^ Tfh cells between two groups (HC and schistosomiasis patients) (*p* \< 0.05). Data shown are the mean percentage of Tfh cells in total CD4^+^T cells in individual subjects. The horizontal lines represent the median values.](ijbsv11p1049g001){#F1}

![**The phenotype of CXCR5^+^CD4^+^ Tfh cells in chronic schistosomiasis patients and healthy controls.**(A) ICOS^+^ CXCR5^+^CD4^+^Tfh cells in total CD4^+^ T cells from chronic schistosomiasis patients and healthy controls. (B) The expression of ICOS in isotype (gray), chronic schistosomiasis patients (red) and healthy controls (black). Samples were gated for CXCR5^+^CD4^+^ Tfh cells. (C) Comparison of the percentages of ICOS^+^ CXCR5^+^CD4^+^Tfh cells in chronic schistosomiasis patients and healthy controls (*p* \< 0.05). (D) PD-1^+^ CXCR5^+^CD4^+^ Tfh cells in total CD4^+^ T cells of chronic schistosomiasis patients and healthy controls. (E) The expression of PD-1 in isotype (gray), chronic schistosomiasis patients (red) and healthy controls (black). Samples were gated for CXCR5^+^CD4^+^ Tfh cells. (F) Comparison of the percentages of PD-1^+^ CXCR5^+^CD4^+^ Tfh cells in chronic schistosomiasis patients and healthy controls (*p* \< 0.05).](ijbsv11p1049g002){#F2}

![**Correlation of IL-21 levels and circulating Tfh cells in schistosomiasis patients and HC.**(A) Detection of IL-21 mRNA expression. (\* *p* \< 0.05). (B) Detection of Bcl-6 mRNA expression. (C) Detection of c-Maf mRNA expression. (D) Levels of IL-21 in sera from schistosomiasis patients and HC. Data shown are the mean ± SD, the horizontal lines show the median. (E-G) Relationship of IL-21 levels in sera and the percentage of CXCR5^+^CD4^+^ Tfh cells, ICOS^high^ CXCR5^+^CD4^+^ Tfh cells and PD-1^high^ CXCR5^+^CD4^+^ Tfh cells in HC; (H-J) Relationship of IL-21 levels in sera and the percentage of CXCR5^+^CD4^+^ Tfh cells, ICOS^high^ CXCR5^+^CD4^+^ Tfh cells and PD-1^high^ CXCR5^+^CD4^+^ Tfh cells in schistosomiasis patients.](ijbsv11p1049g003){#F3}

![**Levels of SEA-antibodies in sera from schistosomiasis patients and HC.**(A) Levels of serum SEA-specific IgG; (B) Levels of serum SEA-specific IgG1; (C) Levels of serum SEA-specific IgG4. Data are expressed as the mean ± SD. (\*\* *p* \< 0.01).](ijbsv11p1049g004){#F4}

###### 

**Correlation analysis of the levels of SEA specific IgG, IgG1 and IgG4 with the percentages of circulating Tfh cells in schistosomiasis patients (n = 11).** Relationship of the percentages of CXCR5^+^ CD4^+^Tfh cells with (A) SEA specific IgG, (B) SEA specific IgG1, and (C) SEA specific IgG4. Relationship of the percentages of ICOS^+^CXCR5^+^CD4^+^Tfh cells with (D) SEA specific IgG, (E) SEA specific IgG1, and (F) SEA specific IgG4. The percentages of PD-1^+^CXCR5^+^ CD4^+^Tfh cells were positively associated with (G) SEA specific IgG, (H) SEA specific IgG1, and (I) SEA specific IgG4 (*p* \< 0.05).
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